WHO says it is SUSPENDING its trial of anti-malaria drug hydoxychloroquine in coronavirus patients citing safety concerns - a day after Trump boasts about finishing his prescription
Hydroxychloroquine is most typically used to treat malaria, lupus and arthritis
The WHO had been testing the drug as part of its Solidarity trial looking at the safety and efficacy of four medications against coronavirus
But a study on Friday revealed higher mortality rates among COVID-19 patients who took the drug
On Monday, the WHO announced it was suspending the hydroxychloroquine arm of its trial over safety concerns
[link to www.dailymail.co.uk (secure)]